2020 ICD-10-CM Diagnosis Code C92.10

Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission

    2016 2017 2018 2019 2020 Billable/Specific Code
  • C92.10 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • Short description: Chronic myeloid leuk, BCR/ABL-positive, not achieve remis
  • The 2020 edition of ICD-10-CM C92.10 became effective on October 1, 2019.
  • This is the American ICD-10-CM version of C92.10 - other international versions of ICD-10 C92.10 may differ.
Applicable To
  • Chronic myeloid leukemia, BCR/ABL-positive with failed remission
  • Chronic myeloid leukemia, BCR/ABL-positive NOS
The following code(s) above C92.10 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to C92.10:
  • C00-D49
    2020 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • C81-C96
    2020 ICD-10-CM Range C81-C96

    Malignant neoplasms of lymphoid, hematopoietic and related tissue

    Type 2 Excludes
    • Kaposi's sarcoma of lymph nodes (C46.3)
    • secondary and unspecified neoplasm of lymph nodes (C77.-)
    • secondary neoplasm of bone marrow (C79.52)
    • secondary neoplasm of spleen (C78.89)
    Malignant neoplasms of lymphoid, hematopoietic and related tissue
  • C92
    ICD-10-CM Diagnosis Code C92

    Myeloid leukemia

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Includes
    • granulocytic leukemia
    • myelogenous leukemia
    Type 1 Excludes
    • personal history of leukemia (Z85.6)
    Myeloid leukemia
  • C92.1
    ICD-10-CM Diagnosis Code C92.1

    Chronic myeloid leukemia, BCR/ABL-positive

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Applicable To
    • Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive
    • Chronic myelogenous leukemia, t(9;22) (q34;q11)
    • Chronic myelogenous leukemia with crisis of blast cells
    Type 1 Excludes
    • atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
    • chronic myelomonocytic leukemia (C93.1-)
    • chronic myeloproliferative disease (D47.1)
    Chronic myeloid leukemia, BCR/ABL-positive
Approximate Synonyms
  • Chronic myeloid leukemia
  • Leukemia, chronic myeloid
ICD-10-CM C92.10 is grouped within Diagnostic Related Group(s) (MS-DRG v37.0):
  • 820 Lymphoma and leukemia with major o.r. Procedure with mcc
  • 821 Lymphoma and leukemia with major o.r. Procedure with cc
  • 822 Lymphoma and leukemia with major o.r. Procedure without cc/mcc
  • 823 Lymphoma and non-acute leukemia with other procedure with mcc
  • 824 Lymphoma and non-acute leukemia with other procedure with cc
  • 825 Lymphoma and non-acute leukemia with other procedure without cc/mcc
  • 840 Lymphoma and non-acute leukemia with mcc
  • 841 Lymphoma and non-acute leukemia with cc
  • 842 Lymphoma and non-acute leukemia without cc/mcc

Convert C92.10 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
Code annotations containing back-references to C92.10:
  • Code Also: I27.29
    ICD-10-CM Diagnosis Code I27.29

    Other secondary pulmonary hypertension

      2018 - New Code 2019 2020 Billable/Specific Code
    Applicable To
    • Group 5 pulmonary hypertension
    • Pulmonary hypertension with unclear multifactorial mechanisms
    • Pulmonary hypertension due to hematologic disorders
    • Pulmonary hypertension due to metabolic disorders
    • Pulmonary hypertension due to other systemic disorders
    Code Also
    • other associated disorders, if known, such as:
    • chronic myeloid leukemia (C92.10- C92.22)
    • essential thrombocythemia (D47.3)
    • Gaucher disease (E75.22)
    • hypertensive chronic kidney disease with end stage renal disease (I12.0, I13.11, I13.2)
    • hyperthyroidism (E05.-)
    • hypothyroidism (E00-E03)
    • polycythemia vera (D45)
    • sarcoidosis (D86.-)
  • Type 1 Excludes: C92.0
    ICD-10-CM Diagnosis Code C92.0

    Acute myeloblastic leukemia

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Applicable To
    • Acute myeloblastic leukemia, minimal differentiation
    • Acute myeloblastic leukemia (with maturation)
    • Acute myeloblastic leukemia 1/ETO
    • Acute myeloblastic leukemia M0
    • Acute myeloblastic leukemia M1
    • Acute myeloblastic leukemia M2
    • Acute myeloblastic leukemia with t(8;21)
    • Acute myeloblastic leukemia (without a FAB classification) NOS
    • Refractory anemia with excess blasts in transformation [RAEB T]
    Type 1 Excludes
    • acute exacerbation of chronic myeloid leukemia (C92.10)
    • refractory anemia with excess of blasts not in transformation (D46.2-)
ICD-10-CM Codes Adjacent To C92.10
C91.9 Lymphoid leukemia, unspecified
C91.90 …… not having achieved remission
C91.91 …… in remission
C91.92 …… in relapse
C92 Myeloid leukemia
C92.0 Acute myeloblastic leukemia
C92.00 …… not having achieved remission
C92.01 …… in remission
C92.02 …… in relapse
C92.1 Chronic myeloid leukemia, BCR/ABL-positive
C92.10 …… not having achieved remission
C92.11 …… in remission
C92.12 …… in relapse
C92.2 Atypical chronic myeloid leukemia, BCR/ABL-negative
C92.20 …… not having achieved remission
C92.21 …… in remission
C92.22 …… in relapse
C92.3 Myeloid sarcoma
C92.30 …… not having achieved remission
C92.31 …… in remission
C92.32 …… in relapse

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.